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Fetal macrosomia in diabetic pregnancies has been attributed to hyperinsulinaemia [1] [2] [3] , which occurs in response to fetal hyperglycaemia. However, few studies have reported the glycaemic control of the fetus during the prenatal period [4] [5] [6] [7] [8] . Hypoglycaemia in infants of diabetic mothers, often observed at delivery, is an insufficient guide to the assessment of hypoglycaemia in fetal life. The glycosylated haemoglobin (Gly-Hb) concentration tends to reflect glycaemic control during the previous weeks, and its determination after delivery may help in the assessment of glycaemic control in utero. Because of difficulties in measuring Gly-Hb in neonatal blood using isoelectric focussing [5, 9, 10] or cation exchange chromatography [11] [12] [13] [14] , the thiobarbituric acid (TBA) color• chemical assay or affinity chromatography method [15, 16] are the most appropriate for such assessment. The TBA procedure directly measures ketoamine linkage. In addition, the C-peptide levels at delivery allow estimation of insulinaemia in the fetus.
The aim of the present study was to determine the glycaemic control of infants of diabetic mothers in the per• period. For this purpose, infant-mother paired samples from control and insulin-dependent diabetic pregnancies were studied.
Subjects and methods

Subjects
Infants and their mothers attended the Department of Paediatrics and Gynaecology, CHU Morvan, Brest, France. 'Three groups were studied: group 1:11 control mothers with no history of diabetes and with a normal oral glucose tolerance test according to the criteria of O'Sullivan and Mahan [18] ; group 2:13 gestational diabetic patients with an abnormal glucose tolerance test (White's Class A), all were treated with insulin; group 3: seven Type I diabetic women (three White's Class B, two Class C and two Class D). All diabetic patients were treated with insulin. The number of births by normal vaginal delivery were respectively seven, ten and three and by Caesarean section four, three and four in the three groups. All mothers were given a slow regular glucose infusion at a rate of 4-5 g/h for the 2-3 h before delivery. The mean gestational ages for the infants were respectively: group t: 37.4+2.3 weeks (range 35-40 weeks), group 2: 38.4+ 1.4weeks (range 36-40weeks) and group 3:36.7 • 0.7 weeks (range 36-38 weeks). Ultrasonography was used for assessment of gestational age, and the gestational ages were ascertained at delivery [19] . The mean infant birth weights were: group 1: 2.41• (range 1.90-3.42 kg), group 2: 3.38 +_ 0.35 kg (range 2.40-3.90 kg), group 3 : 3.39• kg (range 2.70-3.70kg). The control infants presented a heterogeneous population with various reasons for admission to hospital (infection, minor respiratory distress syndromes), but none had hypoglycaemia (plasma glucose < 1.65 mmol/l) during the first 3 h of neonatal life.
No infant was fed by maternal milk during the 7 days after birth. Between days 0 and 3, five infants in group 1 and three infants in group 2 were fed continuously with Alprem (Nestl6, Vevey, Switzerland) by gastric intubation, six and ten in the same groups by humanised milk (SMA, Wyeth-Byla, Paris, France). Between days 3 and 7 the infants were fed every 3 h with the same milk used between days 0 and 3. In group 3, every infant received humanised milk (SMA). Moreover, glucose was infused intravenously in two infants on days 0 and 1, in the five other infants 2% lactose was added to the humanised milk. The oral diet with humanised milk and 2% lactose (4.5-6.5 g lactose/day) was given between days 3 and 7 in all the infants of this group.
Methods
All the determinations were carried out on venous blood. Gly-Hb was measured using a TBA semi-automated procedure [17] and blood glucose and C-peptide were analysed (see below).
Whole blood samples were collected in EDTA and immediately centrifuged (1400 g for t0 rain). Maternal samples were drawn within 6 h of delivery and infant samples were drawn within 3 h of delivery. Blood samples were collected before feeding at 08.00 h from the infants on day 7 of life. Plasma samples were analysed for glucose by a glucose oxidase technique using a glucose analyser (Beckman, Fullerton, California, USA) and for C-peptide by radioimmunoassay (mat C peptid, Mallinckrodt, Diedzenbach, FRG). The sensitivity of the Cpeptide assay was 10 pmol/l. The coefficient of variation was < 10% and according to the supplier, cross-reaction with human proinsulin was < 10%. Haemolysates for Gly-Hb assays were prepared within 12 h from saline (NaC1 0.15 mol/1)-solution-washed erythrocytes by osmotic lysis with water, shaking with carbon tetrachloride and subsequent centrifugation (2000 g for 10 rain) to remove cellular debris. The overnight dialyzed (against NaC1, 0.15 mol/1) haemolysates were adjusted to 100 g/1 and hydrolyzed by the technique of Pecoraro et al. [20] . After hydrolysis, the 5-hydroxymethylfurfural (5-HMF) was determined, using TBA colorimetric reaction by means of an auto-analyser II (Technicon, Domont, France) as described previously [J7]. The method was standardized using a poll of frozen haemoglobin, distributed in I ml aliquots and stored at -20 ~ Results were expressed in nmol 5-HMF/mg haemoglobin. The between-assay precision for the standard was 4.8%. All the determinations for glucose, Cpeptide and Gly-Hb were carried out in duplicate.
Statistical analysis included Student's unpaired t-test and linear regression analysis.
Results
There were no significant differences in gestational age between the study groups. The infants of diabetic mothers were heavier than control infants (p< 0.001). The results of blood glucose, C-peptide and Gly-Hb at delivery and on day 7 after birth for the three groups studied are summarised in Table 1 . At delivery the plasma glucose concentration was lower in infants of diabetic mothers compared with controls (p < 0.02), especially in infants of group3 mothers (Class B-D; p<0.001), which suggests neonatal hypoglycaemia in infants of diabetic mothers. The differences between control infants and infants of group 2 mothers (Class A) were not significant. It was noteworthy that the differences between blood glucose concentrations at delivery and 7 days after were always significant (p < 0.05 for infants of groupJ and 2 mothers, p<0.001 for infants of group 3 mothers), but the differences between the glycaemia on day 7 of life were not significant between any group. Therefore neonatal hypoglycaemia in infants of diabetic mothers is a transient condition which can be corrected easily. As expected, plasma glucose concentrations at delivery were higher in diabetic mothers than in control mothers (p<0.001), especially in group3 (9.8 ___ 3.6 versus 3.73 _ 0.59 mmol/1, p< 0.001). Serum glucose levels were significantly lower in infants at birth than in paired mothers for every group, in group I (p < 0.05); this difference was highly significant in group 3 (p < 0.001).
At delivery, the mean C-peptide level of Class A diabetic mothers was not significantly lower than control mothers. The C-peptide levels were higher in the infants of diabetic mothers, especially in the infants of group 3 (1248 + 1010 versus 380 + 160 pmol/1, p< 0.05). In all groups, the C-peptide levels increased between delivery and day 7, so the differences remained significant between control infants and infants of group 3 mothers; in this group hyperinsulinaemia was persistent 7 days after delivery. In group 2 infants, the mean C-peptide level was slightly higher than controls at delivery, but 7 days after, the pancreatic secretion was the same for both. More interesting were the results of Gly-Hb. The Gly-Hb of diabetic mothers was higher than in controls (p<0.05 between controls and group3 mothers). No significant difference was found between the Gly-Hb of pregnant women and non-pregnant women (1.66 +_ 0.16 versus 1.62 +_ 0.11 nmol 5-HMF/mg Hb). For infants in every group the Gly-Hb was 20-40% lower than in control adults. The Gly-Hb concentrations were lower in infants of diabetic mothers compared to control infants (p < 0.05), especially in babies of group 3 mothers. In every group a slight increase was found between infants' Gly-Hb concentration on days 0 and 7, but the Gly-Hb level remained lower in infants of diabetic mothers than in control infants (p< 0.01; 7 days after birth). By regression analysis a correlation could be found between the infants' glycaemia and Gly-Hb at delivery (r=0.44, n=29, p<0.02; Fig.l ) and between C-peptide levels and Gly-Hb concentrations determined in infants at delivery (r= -0.42, n= 28, p< 0.05 ; Fig. 2 ). The decrease in the infants' glycaemia was associated with an increase of C-peptide levels at delivery, but a significant correlation between both parameters failed. The increase in birth weight was associated with an increase of C-peptide levels at delivery (p < 0.05), but no correlation could be found between maternal GlyHb levels and the birth weights of their infants. A comparison of Gly-Hb in infants and their mothers showed an increase in mother Gly-Hb with a decrease in infant Gly-Hb but a significant correlation between both parameters could not be found. In groups 2 and 3 the increase in mothers' glycaemia was associated with a decrease in infants' glycaemia, but the correlation was not significant.
Discussion
Hypoglycaemia and macrosomia are well recognised in infants of diabetic mothers. Macrosomia is demonstrated clearly in this study, as the gestational age of the infants was not significantly different. A variable incidence of hyperglycaemia or hypoglycaemia has been reported [2, [21] [22] [23] [24] [25] . In those studies, the increases of glycaemia in infants of diabetic mothers were never significant. Moreover the determinations were carried out on cord blood which does not reflect exactly the infants' metabolism as reported for other blood parameters [26, 27] .
Accurate assessment of fetal hyperinsulinism by the levels of insulin in blood in infants of diabetic mothers is usually not feasible, because of interference in the insulin immunoassay by the transplacental passage of maternal antibodies generated by exogenous insulin therapy. Instead of insulin, measurement of C-peptide levels provides an accurate assessment of the secretion of endogenous fetal insulin, despite the presence of circulating antibodies. Serum C-peptide levels in the longterm diabetic patients were very low in contrast to their infants as previously reported [22] . Thus, insulin-treated mothers, who become diabetic during pregnancy, had C-peptide levels close to the control group of mothers. Class A diabetic mothers have insufficient fl-cell activity which is supported by the increase of glycaemia at delivery (p< 0.01 versus control). They require exogenous insulin to reduce the increase in blood glucose. The increase of C-peptide levels in every group of infants between days 0 and 7 can be explained by the stimulation of insulin secretion induced by oral feeding. Therefore in infants of diabetic mothers the hyperinsulinism was not rapidly corrected even after 7 days of extra-uterine life. The addition of 2% lactose to the humanised milk in the feeding of those infants of diabetic mothers is insufficient by itself to explain the maintenance of the high insulin secretion in those infants. In spite of an obvious corrected glycaemia, the nutritional control of those infants beyond day 7 of life must be required to avoid a new decrease of blood glucose.
Measurement of glycosylated haemoglobin provides an integrated, retrospective index of glucose control, reflecting the mean blood glucose concentration over the previous weeks before its measurement. The determination of Gly-Hb in neonatal blood is a difficult task using ion exchange or isoelectric focussing methods. But, colorimetric assay offers a convenient tool for measuring the amount of hexose chemically linked to proteins. The technique used here, and affinity chromatography used by other authors [15, 16] , permits the assessment of fetal glycosylated haemoglobin. In every group the Gly-Hb level was 22-37% lower in infants than in mothers, which is in agreement with differences reported using the affinity chromatography technique [15, 16] . This can be explained in three ways: (1) by the lower blood glucose concentration in the fetus compared to its mother, (2) by the shorter half-life of fetal haemoglobin compared with adult haemoglobin [28] , and (3) by the decrease in fetal erythrocyte membrane permeability to glucose [29] . The lower Gly-Hb values in the Class B, C and D infants might be due to the increase in erythropoiesis of such infants. However, the shorter half-life of the erythrocyte in infants of diabetic mothers was described and attributed to the fact that they are born before term [2] . In this study, as control infants have the same gestational age, the half-life of erythrocytes would be comparable. However the infants affected by the maternal diabetic process may have an abnormal haematopoiesis, such a study merits investigation.
There have been few studies [4] [5] [6] [7] [8] [15] [16] of Gly-Hb in infants of diabetic mothers. Fitzgerald et al. [5] , using isoelectric focussing, found that the level of Gly-Hb in infants of diabetic mothers could not be correlated to an increase of Gly-Hb in their mothers. Schwartz et al. [30] , using isoelectric focussing and DEAE cellulose ion exchange chromatography, were not able to demonstrate any difference in acetylation or glycosylation occurring in the infants of control, gestational diabetic or Class B-D diabetic mothers. Caangay et al. [311, in a preliminary communication, using the TBA colorimetric method, found no difference between infants of control and diabetic mothers. For Zeller et al. [8] , using the TBA colorimetric method, the Gly-Hb values of control infants were not significantly lower than infants of diabetic mothers, while a significant correlation was found between maternal and infants' Gly-Hb. Sosenko et al. [6] and Worth et al. [7] have reported a significant relationship between maternal and infant Gly-Hb. Moreover, a correlation between serum C-peptide levels and TBA value in infants of diabetic mothers was found, but cord blood samples were used [61. In our study, the significant lower Gly-Hb level in infants of diabetic mothers than in control infants, at delivery and 7 days after birth, associated with a significant correlation between glycaemia and Gly-Hb, and between C-peptide levels and infants' Gly-Hb at delivery, may suggest normoglycaemia or hypoglycaemia during the later weeks of fetal life secondary to fetal hyperinsulinism. To confirm such a hypothesis the half-life of erythrocytes of infants of diabetic mothers should be elucidated further. Moreover, the determination of Gly-Hb using a high pressure liquid chromatography procedure [321, which has the main advantage of measuring 5-HMF without interference by background colour absorbance, should give more accurate information about 5-HMF released from fetal haemoglobin.
